Ono Pharmaceutical Co., Ltd. (OTCMKTS:OPHLY – Get Free Report)’s stock price was up 2% on Tuesday . The stock traded as high as $4.20 and last traded at $4.1730. Approximately 27,531 shares traded hands during mid-day trading, a decline of 90% from the average daily volume of 277,253 shares. The stock had previously closed at $4.0930.
Ono Pharmaceutical Trading Up 2.0%
The business’s 50 day moving average price is $3.90 and its 200-day moving average price is $3.72.
About Ono Pharmaceutical
Ono Pharmaceutical Co, Ltd., together with its subsidiaries, produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide. It offers Opdivo Intravenous Infusion and Kyprolis Intravenous Injection for malignant tumors; Emend capsules/Proemend intravenous injections for chemotherapy-induced nausea and vomiting; Demser capsules for the symptoms in patients with pheochromocytoma; and Mektovi, Velexbru, and Braftovi capsules for malignant tumors, as well as ADLUMIZ tablets for cancer cachexia.
Featured Stories
- Five stocks we like better than Ono Pharmaceutical
- Market Cap Calculator: How to Calculate Market Cap
- CoreWeave’s Guidance Cut: A Buying Opportunity in Disguise?
- What is the Shanghai Stock Exchange Composite Index?
- Strategy Shares Plunge as Bitcoin Retreats—More Pain Ahead?
- Differences Between Momentum Investing and Long Term Investing
- BigBear.ai Stock Is Range-Bound—Wall Street Isn’t Buying the Hype
Receive News & Ratings for Ono Pharmaceutical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ono Pharmaceutical and related companies with MarketBeat.com's FREE daily email newsletter.
-limited-logo.png?v=20220228095611&h=45&w=95&zc=2){kind=logo}
